NCT05924971View on ClinicalTrials.gov

Aspirin for Postpartum Patients With Preeclampsia

PHASE2RecruitingINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

July 26, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Preeclampsia Postpartum
Interventions
DRUG

Aspirin 81Mg Ec Tab

Aspirin 81 mg 1 tablet by mouth. Participants randomized to receive aspirin in addition to standard blood pressure management will receive the study medication nightly at 20:00, with first dose initiated within 24 hours of delivery.

Trial Locations (1)

90740

RECRUITING

Miller Children's and Women's Hospital, Long Beach/MemorialCare Long Beach, Long Beach

All Listed Sponsors
collaborator

University of California, Irvine

OTHER

lead

MemorialCare Health System

OTHER